These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12172348)

  • 1. Prospective 6-year trial with clozapine: negative symptoms in outpatients with schizophrenia improve despite intermittent positive symptoms.
    Gaertner I; Gaertner HJ; Vonthein R; Dietz K
    J Clin Psychopharmacol; 2002 Aug; 22(4):437-8. PubMed ID: 12172348
    [No Abstract]   [Full Text] [Related]  

  • 2. Clozapine plasma level monitoring for prediction of rehospitalization schizophrenic outpatients.
    Stieffenhofer V; Saglam H; Schmidtmann I; Silver H; Hiemke C; Konrad A
    Pharmacopsychiatry; 2011 Mar; 44(2):55-9. PubMed ID: 21207352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating depression in schizophrenia.
    Lund BC; Perry PJ; Miller DD
    Am J Psychiatry; 2001 Sep; 158(9):1528-9. PubMed ID: 11532750
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clozapine in the treatment of schizophrenia].
    Raitasuo V
    Duodecim; 2000; 116(11):1199-204; quiz 1205. PubMed ID: 11989005
    [No Abstract]   [Full Text] [Related]  

  • 5. Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome.
    Buchanan RW; Breier A; Kirkpatrick B; Ball P; Carpenter WT
    Am J Psychiatry; 1998 Jun; 155(6):751-60. PubMed ID: 9619146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of ziprasidone and clozapine in treatment-resistant schizophrenia.
    Zink M; Mase E; Dressing H
    Hum Psychopharmacol; 2004 Jun; 19(4):271-3. PubMed ID: 15181656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine augmented with glutamate modulators in refractory schizophrenia: a review and metaanalysis.
    Veerman SR; Schulte PF; Begemann MJ; Engelsbel F; de Haan L
    Pharmacopsychiatry; 2014 Sep; 47(6):185-94. PubMed ID: 25002291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clozapine--the neglected potential].
    Munitz H
    Harefuah; 2012 May; 151(5):298-300, 318, 317. PubMed ID: 22844735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schizophrenia, drug therapy, and monitoring.
    Bradford DW; Stroup TS
    N Engl J Med; 2004 Jan; 350(4):415-6. PubMed ID: 14736938
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic drug monitoring of clozapine in relapse prevention: a five-year prospective study.
    Gaertner I; Gaertner HJ; Vonthein R; Dietz K
    J Clin Psychopharmacol; 2001 Jun; 21(3):305-10. PubMed ID: 11386494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
    de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS
    J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical use of the newer antipsychotic drugs.
    Perry PJ
    Am J Health Syst Pharm; 1995 Feb; 52(3 Suppl 1):S9-14. PubMed ID: 7538437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Obsessive-compulsive symptoms in schizophrenia during treatment with clozapine and conventional antipsychotic drugs].
    Galvez-Buccollini JA; Fiestas F; Herrera P; Vega-Dienstmaier JM; Guimas B; Mazzotti G
    Actas Esp Psiquiatr; 2004; 32(4):211-5. PubMed ID: 15232749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clozapine and treatment of negative symptoms].
    Lançon C; Farisse J; Llorca PM
    Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained long-term improvement with clozapine in schizophrenia.
    Oliveira-Souza Rde O; Marrocos RP; De Figueiredo WM
    Arq Neuropsiquiatr; 1999 Mar; 57(1):18-22. PubMed ID: 10347718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promising use of minocycline augmentation with clozapine in treatment-resistant schizophrenia.
    Qurashi I; Collins JD; Chaudhry IB; Husain N
    J Psychopharmacol; 2014 Jul; 28(7):707-8. PubMed ID: 24646811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing. Switching schizophrenia treatments.
    Marven M
    Health Serv J; 2005 Mar; 115(5948):suppl 12. PubMed ID: 15825666
    [No Abstract]   [Full Text] [Related]  

  • 18. Subjective response to clozapine and risperidone treatment in outpatients with schizophrenia.
    Kim JH; Kim SY; Ahn YM; Kim YS
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):301-5. PubMed ID: 16309807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia.
    Goff DC; Henderson DC; Evins AE; Amico E
    Biol Psychiatry; 1999 Feb; 45(4):512-4. PubMed ID: 10071726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical monitoring system for clozapine.
    Castle D; Lambert T; Melbourne S; Cox A; Boardman G; Fairest K; Davy M; Goh J; Kuluris B; Berk M
    Australas Psychiatry; 2006 Jun; 14(2):156-68. PubMed ID: 16734644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.